Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Vlachou, Konstantina Tragou, A. Siamidi, Stefanos Kikionis, Angelos– Chatzianagnostou, Anastasis Mitsopoulos, E. Ioannou, V. Roussis, A. Tsotinis (2018)Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan
Journal of Drug Delivery Science and Technology, 44
N. Peppas, J. Sahlin (1989)A simple equation for the description of solute release. III. Coupling of diffusion and relaxation
International Journal of Pharmaceutics, 57
(2010)Formulation and evaluation of gastroretentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs)
K. Khan (1975)The concept of dissolution efficiency
Journal of Pharmacy and Pharmacology, 27
(2016)Almouhammad, Assessment of physicochemical properties of furosemide (40 mg) tablets marketed in Syria
T. Terao, K. Matsuda, H. Shouji (2001)Improvement in site‐specific intestinal absorption of furosemide by Eudragit L100‐55
Journal of Pharmacy and Pharmacology, 53
(2010)mefloquine hydrochloride, J
J. Akbuğa (1989)Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization
International Journal of Pharmaceutics, 53
M. Vlachou, Stefanos Kikionis, A. Siamidi, Konstantina Tragou, Stefania Kapoti, E. Ioannou, V. Roussis, A. Tsotinis (2018)Fabrication and Characterization of Electrospun Nanofibers for the Modified Release of the Chronobiotic Hormone Melatonin
Current Drug Delivery, 16
L. Brodin, T. Jogestrand, F. Larsen, G. Walldius, B. Tedner (1986)Effects of furosemide and slow‐release furosemide on thoracic fluid volumes
Clinical Cardiology, 9
(2017)An IRMPD spectroscopy study, J
Satendra Kumar, A. Mishra (2016)Preformulation study of furosemide
(2010)texture analyzer, Iranian J
(2015)Formulation development, in vitro and ex vivo evaluation, Adv
(2011)in-vitro drug release characterization models, Int
Swapna Sambaraj, Divya Ammula, Vijaykumar Nagabandi (2015)Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in vitro and ex vivo Evaluation.
Advanced pharmaceutical bulletin, 5 3
Stefanie Strauch, Ekarat Jantratid, J. Dressman, H. Junginger, S. Kopp, K. Midha, V. Shah, S. Stavchansky, D. Barends (2011)Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride.
Journal of pharmaceutical sciences, 100 1
S. Oh, S. Han (2015)Loop Diuretics in Clinical Practice
Electrolytes & Blood Pressure : E & BP, 13
Bendgude Tukaram, Iyer Rajagopalan, Poddar Shartchandra (2010)The Effects of Lactose, Microcrystalline Cellulose and Dicalcium Phosphate on Swelling and Erosion of Compressed HPMC Matrix Tablets: Texture Analyzer
Iranian Journal of Pharmaceutical Research : IJPR, 9
(2007)A review, Pharm
M. Vlachou, A. Siamidi, Evanthia Diamantidi, Alexandra Iliopoulou, Ioannis Papanastasiou, V. Ioannidou, Violeta Kourbeli, Angeliki-Sofia Foscolos, Anthony Vocat, S. Cole, V. Karalis, Tahsin Kellici, T. Mavromoustakos (2017)In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I).
Drug Research, 67
(2017)Melatonin complexes, Int
Bendgude Tukaram, Iyer Rajagopalan, Poddar Shartchandra (2010)The Effects of Lactose, Microcrystalline Cellulose and Dicalcium Phosphate on Swelling and Erosion of Compressed HPMC Matrix Tablets: Texture Analyzer.
Iranian Journal of Pharmaceutical Research, 9
A. Apicella, B. Cappello, M. Nobile, M. Rotonda, G. Mensitieri, L. Nicolais (1993)Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release.
Biomaterials, 14 2
G. Pacifici (2013)Clinical Pharmacology of Furosemide in Neonates: A Review
M. Efentakis, A. Koutlis, M. Vlachou (2000)Development and Evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems
AAPS PharmSciTech, 1
Adam Cismesia, Georgina Nicholls, N. Polfer (2017)Amine vs. carboxylic acid protonation in ortho-, meta-, and para-aminobenzoic acid: An IRMPD spectroscopy study.
Journal of molecular spectroscopy, 332
Min Han, Qin Yu, Xuerong Liu, F. Hu, Hong Yuan (2018)Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets
Acta Pharmaceutica, 68
S. Bose, R. Bogner (2007)Solventless Pharmaceutical Coating Processes: A Review
Pharmaceutical Development and Technology, 12
M. Vlachou, A. Siamidi, S. Konstantinidou, Y. Dotsikas (2016)Optimization of Controlled Release Matrix Formulations of the Chronobiotic Hormone Melatonin via Experimental Design
Xingchu Gong, Changquan Sun (2015)A new tablet brittleness index.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 93
Juan Aceves, R. Cruz, E. Hernández (2000)Preparation and characterization of Furosemide-Eudragit controlled release systems.
International journal of pharmaceutics, 195 1-2
M. Vlachou, A. Siamidi, Dimitrios Spaneas, Dimitrios Lentzos, P. Ladia, K. Anastasiou, Ioannis Papanastasiou, Angeliki-Sofia Foscolos, M. Georgiadis, V. Karalis, Tahsin Kellici, T. Mavromoustakos (2017)In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II)
Drug Research, 67
M. Vlachou, A. Siamidi, M. Efentakis (2017)Investigation of a novel “tablets in capsule” theophylline formulation system for modified release
Pharmacy & Pharmacology International Journal, 5
M. Vlachou, G. Papaïoannou (2003)Preparation and Characterization of the Inclusion Complex of Furosemide with Hydroxypropyl-β-Cyclodextrin
Journal of Biomaterials Applications, 17
Xiaohua Huang, E. Mees, P. Vos, Shereen Hamza, B. Braam (2016)Everything we always wanted to know about furosemide but were afraid to ask.
American journal of physiology. Renal physiology, 310 10
Sathish Ummadi, B. Shravani, N. Rao, M. Reddy, B. Sanjeev (2013)Overview on Controlled Release Dosage Form
N. Clear, A. Milton, M. Humphrey, B. Henry, M. Wulff, D. Nichols, R. Anziano, I. Wilding (2001)Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 13 4
M. Vlachou, Marianna Papamichael, A. Siamidi, Irene Fragouli, Pandelis Afroudakis, Rodanthi Kompogennitaki, Y. Dotsikas (2017)Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin Complexes
International Journal of Molecular Sciences, 18
A. Deshmukh, Premch, Nakhat, P. Yeole (2010)Formulation and in-vitro evaluation of self microemulsifying drug delivery system (SMEDDS) of Furosemide
V. Iannuccelli, G. Coppi, E. Leo, Francesca Fontana, M. Bernabei (2000)PVP Solid Dispersions for the Controlled Release of Furosemide from a Floating Multiple-Unit System
Drug Development and Industrial Pharmacy, 26
M. Efentakis, M. Vlachou (2000)Evaluation of High Molecular Weight Poly(Oxyethylene) (Polyox) Polymer: Studies of Flow Properties and Release Rates of Furosemide and Captopril from Controlled-Release Hard Gelatin Capsules
Pharmaceutical Development and Technology, 5
R. Korsmeyer, R. Gurny, E. Doelker, P. Buri, N. Peppas (1983)Mechanisms of solute release from porous hydrophilic polymers
International Journal of Pharmaceutics, 15
AbstractModified release of furosemide from tablet formulations is preferred by patients, because of physiological problems, acute diuresis being the most serious, compared to the forms designed for immediate release. With this in view, we aimed at achieving furosemide’s longer gastric retention and waste minimization by preparing matrix and compression coated tablets incorporating different grades of Eudragit® and poly(ethylene oxide) (PEO), polyvinylpyrrolidone (PVP) and lactose monohydrate. Dissolution profiles of the new formulations were compared with that of the main stream drug Lasix®, 40 mg tablets. The results indicate that the use of Eudragit® in conjunction with either PVP or lactose monohydrate led to a slower release rate in the intestinal fluids compared to Lasix®. Moreover, furosemide release in the intestinal pH from matrix tablets and compression coated tablets was not noticeably different. Formulations incorporating PEO led to sustained release, in intestinal fluids, which depended on the molecular weight of PEO.
Acta Pharmaceutica – de Gruyter
Published: Mar 1, 2020
Keywords: matrix tablets; compression coated tablets; furosemide; Eudragit ®; poly(ethylene oxide); polyvinylpyrrolidone
Access the full text.
Sign up today, get DeepDyve free for 14 days.